These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 31611349)
1. Evaluation of Resistance Development to the Gwt1 Inhibitor Manogepix (APX001A) in Kapoor M; Moloney M; Soltow QA; Pillar CM; Shaw KJ Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31611349 [TBL] [Abstract][Full Text] [Related]
4. Synthesis of analogs of the Gwt1 inhibitor manogepix (APX001A) and in vitro evaluation against Cryptococcus spp. Trzoss M; Covel JA; Kapoor M; Moloney MK; Soltow QA; Webb PJ; Shaw KJ Bioorg Med Chem Lett; 2019 Dec; 29(23):126713. PubMed ID: 31668974 [TBL] [Abstract][Full Text] [Related]
8. Fosmanogepix (APX001) Is Effective in the Treatment of Immunocompromised Mice Infected with Invasive Pulmonary Scedosporiosis or Disseminated Fusariosis. Alkhazraji S; Gebremariam T; Alqarihi A; Gu Y; Mamouei Z; Singh S; Wiederhold NP; Shaw KJ; Ibrahim AS Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31818813 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of Delayed Therapy with Fosmanogepix (APX001) in a Murine Model of Candida auris Invasive Candidiasis. Wiederhold NP; Najvar LK; Shaw KJ; Jaramillo R; Patterson H; Olivo M; Catano G; Patterson TF Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427304 [TBL] [Abstract][Full Text] [Related]
10. Shaw KJ; Schell WA; Covel J; Duboc G; Giamberardino C; Kapoor M; Moloney M; Soltow QA; Tenor JL; Toffaletti DL; Trzoss M; Webb P; Perfect JR Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891599 [TBL] [Abstract][Full Text] [Related]
11. A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility. Garcia-Effron G; Katiyar SK; Park S; Edlind TD; Perlin DS Antimicrob Agents Chemother; 2008 Jul; 52(7):2305-12. PubMed ID: 18443110 [TBL] [Abstract][Full Text] [Related]
12. Zhao M; Lepak AJ; VanScoy B; Bader JC; Marchillo K; Vanhecker J; Ambrose PG; Andes DR Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29378706 [TBL] [Abstract][Full Text] [Related]
13. Candida and candidaemia. Susceptibility and epidemiology. Arendrup MC Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246 [TBL] [Abstract][Full Text] [Related]
15. Low prevalence of fks1 hot spot 1 mutations in a worldwide collection of Candida strains. Castanheira M; Woosley LN; Diekema DJ; Messer SA; Jones RN; Pfaller MA Antimicrob Agents Chemother; 2010 Jun; 54(6):2655-9. PubMed ID: 20368396 [TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals. Eddouzi J; Parker JE; Vale-Silva LA; Coste A; Ischer F; Kelly S; Manai M; Sanglard D Antimicrob Agents Chemother; 2013 Jul; 57(7):3182-93. PubMed ID: 23629718 [TBL] [Abstract][Full Text] [Related]
17. Fosmanogepix (APX001) Is Effective in the Treatment of Pulmonary Murine Mucormycosis Due to Rhizopus arrhizus. Gebremariam T; Alkhazraji S; Alqarihi A; Wiederhold NP; Shaw KJ; Patterson TF; Filler SG; Ibrahim AS Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32205345 [TBL] [Abstract][Full Text] [Related]
18. E1210, a new broad-spectrum antifungal, suppresses Candida albicans hyphal growth through inhibition of glycosylphosphatidylinositol biosynthesis. Watanabe NA; Miyazaki M; Horii T; Sagane K; Tsukahara K; Hata K Antimicrob Agents Chemother; 2012 Feb; 56(2):960-71. PubMed ID: 22143530 [TBL] [Abstract][Full Text] [Related]
19. Fosmanogepix: A Review of the First-in-Class Broad Spectrum Agent for the Treatment of Invasive Fungal Infections. Shaw KJ; Ibrahim AS J Fungi (Basel); 2020 Oct; 6(4):. PubMed ID: 33105672 [TBL] [Abstract][Full Text] [Related]